The latest machine learning, A.I., and data career topics from across both academia and industry are
Explore the groundbreaking Mamba model, a potential game-changer in AI that promises to outpace the
Explore mind-blowing storytelling with Cole Nussbaumer Knaflic in this episode. Audience favorite an
AlphaGeometry, intuitive AI, and geometric deduction: In this week’s Five-Minute Friday, Super Data
ChatGPT applications and data-driven beer: Beer brewer and Super Data Science regular listener Beau
Explore the future of coding with poolside co-founder and CEO Jason Warner as he explores the potent
Explore the future of collaborative ML workflows in this engaging episode with Dr. Greg Michaelson,
Jon Krohn interviews Hilke Schellmann about the ethics of recruitment algorithms, the field’s curren
Venture capital and AI, and how to succeed with an AI company in 2024: Rasmus Rothe, Cofounder of Me
Explore the transformative power of AI in science. Jon Krohn reviews the groundbreaking AI-driven di
Data science for clean energy takes center stage as Emily Pastewka from Palmetto joins Jon Krohn thi
Artificial General Intelligence gets a new definition: This episode introduces Google DeepMind’s pap
Attention and transformers in LLMs, the five stages of data processing, and a brand-new Large Langua
Jon’s continuous calendar for 2024 is here! Now in an updated format, learn about its unique layout
2024 data science trends take the spotlight in this special episode, where Jon joins Sadie St. Lawre
2023: A year of great movement and change. Technological developments have rocketed generative AI’s
Chatbots, large language models and generative AI: Founder of Quickchat AI Piotr Grudzień believes t
Join us on a brief journey through the AI world in 2023. A year ago, GPT-3.5 crafting our holiday me
Data visualization remains at the forefront as Dr. Alberto Cairo from the University of Miami guides
Sam Altman’s exit and rehiring, AGI, and OpenAI’s Q*: In this week’s Five-Minute Friday, Jon Krohn p
AI Protein design, machine learning and cancer care, and pharmaceuticals: At Exazyme, CEO and Co-Fou